Bupivicaine to Reduce Postoperative Pain in Laparoscopic Ventral Hernia Repair

Intraoperative Local Anesthesia for Management of Postoperative Pain Following Laparoscopic Ventral Hernia Repair: a Prospective Double-blind Randomized Trial

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01530815

Enrollment

Registered

2012-02-10

Start date

2011-08-31

Completion date

2013-01-31

Last updated

2012-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

The investigators are testing to see if infusion of bupivicaine between the mesh and abdominal wall can reduce postoperative pain and decrease use of narcotics in the postoperative setting.

Detailed description

The primary objective of this study is to test different methods for pain management following laparoscopic ventral hernia repair. We hypothesize that local analgesic injection between the abdominal wall and mesh intraoperatively during laparoscopic ventral hernia repair will result in a 20% decrease in the use of post-surgery pain medication in the first four hours after surgery.

Interventions

DRUGBupivicaine Infusion

Investigators and Caregivers will be blinded to either 0.9% Normal Saline or 0.5% Bupivicaine infusion between the mesh and abdominal wall

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Patient must be scheduled for a laparoscopic ventral hernia repair at SBCH. If any additional procedure is performed, the subject will be excluded from the study 2. Age 18 or older 3. Patient must agree to complete pain journal postoperatively 4. Informed consent signed and dated by patient. Consenting through a legally authorized guardian will not be accepted due to the necessity of completing a subjective pain journal

Exclusion criteria

1. Any surgical procedure occurring besides the study procedure 2. Any allergy or sensitivity to bupivicaine or its derivatives 3. Less than 18 years of age 4. Patient unable to self report in pain journal due to cognitive disabilities 5. Discharged less than 4 hours post-surgery

Design outcomes

Primary

Measure	Time frame	Description
Pain	24 hours	We will measure pain based on pain journal and usage of postoperative pain medication

Countries

United States

Contacts

Primary ContactSteve Chang, MD

s1chang@sbch.org805-637-0217

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026